WIF1 and acute lymphoblastic leukemia: A significant increase in miR-181a-5p was observed in multiple leukemia cell lines and acute lymphocytic leukemia samples, and miR-181a-5p activates the Wnt/β-catenin signaling pathway by inhibiting WIF1, thus promoting leukemia cell growth.15